Phase
Condition
Colorectal Cancer
Colon Cancer
Colon Cancer; Rectal Cancer
Treatment
N/AClinical Study ID
Ages 20-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with histologically proven metastatic colorectal cancer for whom treatmentwith cetuximab in 1st line setting, is planned as part of routine clinical practice,as per the locally approved label and the best scientific information; the decision toprescribe cetuximab is at the sole discretion of the investigator. The choice ofstandard chemotherapy regimen for 1st line treatment of colorectal cancer is also atthe sole discretion of the Investigator, based upon routine clinical practice.
Patients aged 20 years and above.
Patients who are molecularly diagnosed as having RAS wild-type mCRC.
Patients who are willing to provide blood samples during the study
Patients who are willing, and able and give, signed informed consent.
Exclusion
Exclusion Criteria:
Patients having a history of prior exposure to any anti-EGFR therapy.
Contra-indications to cetuximab as per locally approved label.
Study Design
Study Description
Connect with a study center
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung,
TaiwanActive - Recruiting
National Cheng Kung University Hospital
Tainan,
TaiwanActive - Recruiting
Cathay General Hospital
Taipei,
TaiwanSite Not Available
Taipei Veterans General Hospital
Taipei,
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.